<?xml version="1.0" encoding="UTF-8"?>
<p id="p0050">Docking experiment is performed using the optimized COVID-19 and SARS (PDB ID: 
 <ext-link ext-link-type="uri" xlink:href="pdb:6NUR" id="ir0015" xmlns:xlink="http://www.w3.org/1999/xlink">6NUR</ext-link>, chain A) RdRps by the aid of AutoDock Vina software implemented in SCIGRESS [
 <xref rid="bb0225" ref-type="bibr">45</xref>]. Eight different compounds are tested against Wuhan COVID-19 RdRp, including Sofosbuvir, IDX-184, Ribavirin, Remdisivir, Guanosine triphosphate (GTP), Uracil triphosphate (UTP), Cinnamaldehyde, and Thymoquinone. Sofosbuvir is an approved drug by the Food and Drugs Administration (FDA) against Hepatitis C Virus (HCV) Non-structural protein 5 (NS5B) RdRp in the year 2013 [
 <xref rid="bb0095" ref-type="bibr">19</xref>,
 <xref rid="bb0230" ref-type="bibr">[46]</xref>, 
 <xref rid="bb0235" ref-type="bibr">[47]</xref>, 
 <xref rid="bb0240" ref-type="bibr">[48]</xref>]. It gives excellent results against other viruses including the Zika virus [
 <xref rid="bb0080" ref-type="bibr">16</xref>,
 <xref rid="bb0085" ref-type="bibr">17</xref>,
 <xref rid="bb0245" ref-type="bibr">49</xref>,
 <xref rid="bb0250" ref-type="bibr">50</xref>]. IDX-184 was under clinical trials against HCV and gave better results compared to other drugs against HCV, MERS and SARS HCoVs, and Zika virus RdRps (2017, [
 <xref rid="bb0055" ref-type="bibr">11</xref>,
 <xref rid="bb0095" ref-type="bibr">19</xref>,
 <xref rid="bb0115" ref-type="bibr">23</xref>,
 <xref rid="bb0255" ref-type="bibr">[51]</xref>, 
 <xref rid="bb0260" ref-type="bibr">[52]</xref>, 
 <xref rid="bb0265" ref-type="bibr">[53]</xref>]). Ribavirin is a broad-acting antiviral drug used to treat different viruses in combination with immunomodulators or direct-acting antivirals [
 <xref rid="bb0270" ref-type="bibr">[54]</xref>, 
 <xref rid="bb0275" ref-type="bibr">[55]</xref>, 
 <xref rid="bb0280" ref-type="bibr">[56]</xref>]. Remdisivir is a nucleotide analog used to treat Ebola virus, Marburg virus, MERS and SARS infections [
 <xref rid="bb0285" ref-type="bibr">57</xref>]. Cinnamaldehyde and Thymoquinone are negative control compounds that proved its inactivity against RdRp in HCV and Zika virus [
 <xref rid="bb0130" ref-type="bibr">26</xref>].
</p>
